Showing results (11-20 of 62) with videos related to
Sort By:
Pageof 7
Cytokine|December 8, 2014
Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapyAnkit Saxena, Sam Khosraviani, Sanjeev Noel, et al.Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|March 29, 2021
Development of Respercise® a Digital Application for Standardizing Home Exercise in COPD Clinical TrialsJohn G Yonchuk, Divya Mohan, Nathan K LeBrasseur, et al.Tissue Engineering and Regenerative Medicine|November 4, 2020
Effect of PDGF-B Gene-Activated Acellular Matrix and Mesenchymal Stem Cell Transplantation on Full Thickness Skin Burn Wound in Rat ModelTamilmahan Paramasivam, Swapan Kumar Maiti, Sangeetha Palakkara, et al.Journal of Cell Science|June 29, 2018
AMP-activated protein kinase promotes epithelial-mesenchymal transition in cancer cells through Twist1 upregulationMeera Saxena, Sai A Balaji, Neha Deshpande, et al.Human Vaccines & Immunotherapeutics|April 6, 2019
Exploring variation in parental worries about HPV vaccination: a latent-class analysisMelissa B Gilkey, Divya Mohan, Ellen M Janssen, et al.European Respiratory Review : an Official Journal of the European Respiratory Society|January 25, 2023
Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPDAriel A Calderon, Colin Dimond, David F Choy, et al.Journal of Medical Economics|December 25, 2018
Healthcare costs and utilization associated with muscle weakness diagnosis codes in patients with chronic obstructive pulmonary disease: a United States claims analysisLaurel Trantham, Mirko V Sikirica, Sean D Candrilli, et al.Nature Protocols|September 8, 2018
PhIP-Seq characterization of serum antibodies using oligonucleotide-encoded peptidomesDivya Mohan, Daniel L Wansley, Brandon M Sie, et al.Nature Protocols|October 27, 2018
Publisher Correction: PhIP-Seq characterization of serum antibodies using oligonucleotide-encoded peptidomesDivya Mohan, Daniel L Wansley, Brandon M Sie, et al.Respiratory Research|October 30, 2025
Safety and tolerability of astegolimab, an anti-ST2 monoclonal antibody: a narrative reviewSteven G Kelsen, Marcus Maurer, Michael Waters, et al.Pageof 7